Research Article
Frequency of Hepatobiliary Manifestations and Concomitant Liver Disease in Inflammatory Bowel Disease Patients
Table 5
Montreal classification for patients with CD and hepatobiliary manifestations.
| | Montreal Classification | CD without hepatobiliary manifestations
N=111 | CD with hepatobiliary manifestations
N=30 |
| | Age at diagnosis, n (%) | | A1: 16 years old | 9 (8.1) | 2 (6.7) | | A2: 17 - 40 years old | 72 (64.9) | 14 (46.7) | | A3: 40 years old | 30 (27.0) | 14 (46.7) | | Location, n (%) | | (L1) Ileal | 20 (18.0) | 5 (16.7) | | (L2) Colonic | 44 (39.7) | 11 (36.7) | | (L3) Ileocolonic | 41 (36.9) | 10 (33.3) | | L1 + superior GI tract (L4) | 1 (0.9) | - | | L2 + L4 | 1 (0.9) | - | | L3 + L4 | 1 (0.9) | - | | No location defined | 3 (2.7) | 4 (13.3) | | Behavior, n (%) | | (B1) Inflammatory | 43 (38.8) | 10 (33.3) | | (B2) Stricturing | 15 (13.5) | 1 (3.3) | | (B3) Penetrating | 8 (7.2) | 3 (10.0) | | B1 + perianal disease (p) | 15 (13.5) | 9 (30.0) | | B2 + p | 8 (7.2) | 4 (13.3) | | B3 + p | 18 (16.2) | - | | No defined behavior | 4 (3.6) | 3 (10.0) |
|
|
CD: Crohn’s disease.
|
